Jaguar Health Explores New Market with Neonorm Dog

Jaguar Health, Inc. has revealed positive insights from market research regarding Neonorm Dog, a plant-based product aimed at maintaining normal stool consistency and gastrointestinal balance in dogs. This marks an extension of Jaguar's Neonorm range, which also includes products for foals and calves.

Research involving veterinary oncologists indicates a significant potential for Neonorm Dog in addressing non-antibiotic digestive support for dogs. Nearly 90% of the specialists considered the product clinically relevant, and close to 80% would recommend it for specific cases.

Feedback from dog owners also showed a strong interest in Neonorm Dog, with 94% expressing intent to purchase. Jaguar plans to launch the product on platforms such as Amazon and Chewy, expanding its reach in the companion animal market.